Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5290]

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

Researchers uncover two-drug combo that halts the growth of cancer cells

Researchers uncover two-drug combo that halts the growth of cancer cells

Drug profiling and gene scissors open new avenues in immunotherapy

Drug profiling and gene scissors open new avenues in immunotherapy

ASCO GI: New drug combinations maintain quality of life for patients with colorectal and liver cancers

ASCO GI: New drug combinations maintain quality of life for patients with colorectal and liver cancers

New opportunity for cancer drug development

New opportunity for cancer drug development

Cheap drug may alleviate treatment-resistance in leukaemia

Cheap drug may alleviate treatment-resistance in leukaemia

New technique predicts which melanoma patients are at risk for cancer recurrence and spread

New technique predicts which melanoma patients are at risk for cancer recurrence and spread

European Commission approves daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for patients with newly diagnosed multiple myeloma who are transplant eligible

European Commission approves daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for...

Pulling the plug on calcium pumps - potential new treatment strategy for pancreatic cancer

Pulling the plug on calcium pumps - potential new treatment strategy for pancreatic cancer

Partnership with China prompts change in care for high-risk type of leukaemia

Partnership with China prompts change in care for high-risk type of leukaemia

More from ecancer